Validation of the CSRFENCE score for prediction of febrile neutropenia during chemotherapy cycles 2–6

Validation of the CSRFENCE score for prediction of febrile neutropenia during chemotherapy cycles 2–6

Abstract Purpose Though febrile neutropenia (FN) risk prediction models are important in clinical practice, their external validation is limited. In this study, we validated the Cycle-Specific Risk of FEbrile Neutropenia after ChEmotherapy (CSRFENCE) score for predicting FN. Methods We reviewed the...

Full description

Bibliographic Details
Main Authors: Razan Zatarah, Nour Faqeer, Aseel Mahmoud, Tasnim Quraan, Lujain Matalka, Aya Kamal, Lama Nazer
Format: Article
Language:English
Published: Springer 2022-10-01
Series:Discover Oncology
Subjects:
Chemotherapy-induced febrile neutropenia
Chemotherapy
Febrile neutropenia
Neoplasms
Prediction
Online Access:https://doi.org/10.1007/s12672-022-00575-1

Similar Items

Similar Items